T Cell Surface Glycoprotein CD3 Epsilon Chain and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Overall Market Size
2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size: 2021 VS 2028
2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top T Cell Surface Glycoprotein CD3 Epsilon Chain Players in Global Market
3.2 Top Global T Cell Surface Glycoprotein CD3 Epsilon Chain Companies Ranked by Revenue
3.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Companies
3.4 Top 3 and Top 5 T Cell Surface Glycoprotein CD3 Epsilon Chain Companies in Global Market, by Revenue in 2021
3.5 Global Companies T Cell Surface Glycoprotein CD3 Epsilon Chain Product Type
3.6 Tier 1, Tier 2 and Tier 3 T Cell Surface Glycoprotein CD3 Epsilon Chain Players in Global Market
3.6.1 List of Global Tier 1 T Cell Surface Glycoprotein CD3 Epsilon Chain Companies
3.6.2 List of Global Tier 2 and Tier 3 T Cell Surface Glycoprotein CD3 Epsilon Chain Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Markets, 2021 & 2028
4.1.2 ND-007
4.1.3 Foralumab
4.1.4 Coltelizumab
4.1.5 AVA-002
4.1.6 Others
4.2 By Type - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue & Forecasts
4.2.1 By Type - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2017-2022
4.2.2 By Type - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2023-2028
4.2.3 By Type - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2021 & 2028
5.1.2 Autoimmune Disorders
5.1.3 Hepatitis B
5.1.4 Multiple Sclerosis
5.1.5 Prostate Cancer
5.1.6 Others
5.2 By Application - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue & Forecasts
5.2.1 By Application - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2017-2022
5.2.2 By Application - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2023-2028
5.2.3 By Application - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2021 & 2028
6.2 By Region - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue & Forecasts
6.2.1 By Region - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2017-2022
6.2.2 By Region - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2023-2028
6.2.3 By Region - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2017-2028
6.3.2 US T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.3.3 Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.3.4 Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2017-2028
6.4.2 Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.4.3 France T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.4.4 U.K. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.4.5 Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.4.6 Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.4.7 Nordic Countries T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.4.8 Benelux T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2017-2028
6.5.2 China T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.5.3 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.5.4 South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.5.5 Southeast Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.5.6 India T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2017-2028
6.6.2 Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.6.3 Argentina T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2017-2028
6.7.2 Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.7.3 Israel T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.7.4 Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
6.7.5 UAE T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, 2017-2028
7 Players Profiles
7.1 Amgen Inc
7.1.1 Amgen Inc Corporate Summary
7.1.2 Amgen Inc Business Overview
7.1.3 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Major Product Offerings
7.1.4 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global Market (2017-2022)
7.1.5 Amgen Inc Key News
7.2 Celgene Corp
7.2.1 Celgene Corp Corporate Summary
7.2.2 Celgene Corp Business Overview
7.2.3 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Major Product Offerings
7.2.4 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global Market (2017-2022)
7.2.5 Celgene Corp Key News
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global Market (2017-2022)
7.3.5 F. Hoffmann-La Roche Ltd Key News
7.4 GlaxoSmithKline Plc
7.4.1 GlaxoSmithKline Plc Corporate Summary
7.4.2 GlaxoSmithKline Plc Business Overview
7.4.3 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Major Product Offerings
7.4.4 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Plc Key News
7.5 MacroGenics Inc
7.5.1 MacroGenics Inc Corporate Summary
7.5.2 MacroGenics Inc Business Overview
7.5.3 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Major Product Offerings
7.5.4 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global Market (2017-2022)
7.5.5 MacroGenics Inc Key News
7.6 Meridigen Biotech Co Ltd
7.6.1 Meridigen Biotech Co Ltd Corporate Summary
7.6.2 Meridigen Biotech Co Ltd Business Overview
7.6.3 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Major Product Offerings
7.6.4 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global Market (2017-2022)
7.6.5 Meridigen Biotech Co Ltd Key News
7.7 Numab Innovation AG
7.7.1 Numab Innovation AG Corporate Summary
7.7.2 Numab Innovation AG Business Overview
7.7.3 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Major Product Offerings
7.7.4 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global Market (2017-2022)
7.7.5 Numab Innovation AG Key News
7.8 SYNIMMUNE GmbH
7.8.1 SYNIMMUNE GmbH Corporate Summary
7.8.2 SYNIMMUNE GmbH Business Overview
7.8.3 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Major Product Offerings
7.8.4 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global Market (2017-2022)
7.8.5 SYNIMMUNE GmbH Key News
7.9 Tiziana Life Sciences Plc
7.9.1 Tiziana Life Sciences Plc Corporate Summary
7.9.2 Tiziana Life Sciences Plc Business Overview
7.9.3 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Major Product Offerings
7.9.4 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global Market (2017-2022)
7.9.5 Tiziana Life Sciences Plc Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Opportunities & Trends in Global Market
Table 2. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Drivers in Global Market
Table 3. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Restraints in Global Market
Table 4. Key Players of T Cell Surface Glycoprotein CD3 Epsilon Chain in Global Market
Table 5. Top T Cell Surface Glycoprotein CD3 Epsilon Chain Players in Global Market, Ranking by Revenue (2021)
Table 6. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Companies, 2017-2022
Table 8. Global Companies T Cell Surface Glycoprotein CD3 Epsilon Chain Product Type
Table 9. List of Global Tier 1 T Cell Surface Glycoprotein CD3 Epsilon Chain Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T Cell Surface Glycoprotein CD3 Epsilon Chain Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Inc Corporate Summary
Table 31. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offerings
Table 32. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corp Corporate Summary
Table 34. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offerings
Table 35. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Ltd Corporate Summary
Table 37. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offerings
Table 38. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Plc Corporate Summary
Table 40. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offerings
Table 41. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), (2017-2022)
Table 42. MacroGenics Inc Corporate Summary
Table 43. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offerings
Table 44. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), (2017-2022)
Table 45. Meridigen Biotech Co Ltd Corporate Summary
Table 46. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offerings
Table 47. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), (2017-2022)
Table 48. Numab Innovation AG Corporate Summary
Table 49. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offerings
Table 50. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), (2017-2022)
Table 51. SYNIMMUNE GmbH Corporate Summary
Table 52. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offerings
Table 53. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), (2017-2022)
Table 54. Tiziana Life Sciences Plc Corporate Summary
Table 55. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product Offerings
Table 56. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. T Cell Surface Glycoprotein CD3 Epsilon Chain Segment by Type in 2021
Figure 2. T Cell Surface Glycoprotein CD3 Epsilon Chain Segment by Application in 2021
Figure 3. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in 2021
Figure 8. By Type - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
Figure 9. By Application - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
Figure 10. By Region - Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
Figure 11. By Country - North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
Figure 12. US T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 13. Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
Figure 16. Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 17. France T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 19. Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 20. Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
Figure 24. China T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 25. Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 28. India T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
Figure 30. Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share, 2017-2028
Figure 33. Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 34. Israel T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 36. UAE T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
